2 completed, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
Follow gallium nitrate: new trials by email Literature Review of gallium nitrate trials Research Report on gallium nitrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro Gan & Lee Insulin Lispro Injection, Humalog - Diabetes Mellitus, Type 1 | Phase 3 | Withdrawn | Gan and Lee Pharmaceuticals, USA | 2019-12-04 | 2020-02-05 | |
| Gan & Lee Insulin Glargine Target Type (2) Evaluating Research Gan & Lee Insulin Glargine Injection, LantusĀ® - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Gan and Lee Pharmaceuticals, USA | 567 | 2017-10-31 | 2022-04-01 |
| Gan & Lee Insulin Glargine Target Type (1) Evaluating Research Gan & Lee Insulin Glargine Injection, LantusĀ® - Diabetes Mellitus, Type 1 | Phase 3 | Completed | Gan and Lee Pharmaceuticals, USA | 576 | 2017-10-31 | 2024-05-14 |
Diabetes Mellitus (3) · Insulin Resistance (3) · Diabetes Mellitus, Type 1 (2) · Diabetes Mellitus, Type 2 (1)
Gan and Lee Pharmaceuticals, USA (3)
United States (3) · Czechia (2) · Germany (2) · Hungary (2) · Poland (2) · Spain (2)
Jia Lu, PhD (2) · Elena A. Christofides, MD, FACE (1) · Elena A. Christofides, MD,FACE (1) · Jia Lu, MD, PhD (1)